- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-G
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2
| EU orphan designation number: | EU/3/11/910
|
| Active ingredient: | NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2 |
| Indication: | Treatment of traumatic spinal cord injury |
| Sponsor: | PHARMAXON
Grand Luminy Technopole case 922, Parc Scientifique de Luminy, F-13288 Marseille CEDEX 09, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 03/10/2011 | Orphan designation | EMA/OD/025/11 | (2011)7043 of 27/09/2011 |
CONTACT
EU links
Directorate General Health & Consumers